Cybin Inc. (OTCMKTS:CLXPF – Get Free Report)’s stock price reached a new 52-week high on Monday . The stock traded as high as $11.66 and last traded at $10.92, with a volume of 201506 shares. The stock had previously closed at $11.41.
Cybin Trading Down 4.3 %
The company has a market cap of $1.62 billion and a P/E ratio of -47.54. The business has a 50 day moving average price of $4.34 and a 200-day moving average price of $1.74.
Cybin Company Profile
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
Featured Articles
- Five stocks we like better than Cybin
- Buy P&G Now, Before It Sets A New All-Time High
- Analysts Predict New Highs for Cybersecurity Stock by Christmas
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Nuclear Power Reaches Critical Mass: Top Stocks to Watch Now
- Using the MarketBeat Dividend Yield Calculator
- 2 Energy Stocks Surging on Billion-Dollar DOE Loan Commitments
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
